30 Years Later, A MacArthur 'Genius' Reflects
By Kat Chow,
WGBH News
| 09. 26. 2013
[Discusses the work of CGS's Osagie Obasogie]
On Wednesday, the MacArthur Foundation announced its newest class of fellows — "geniuses" who have made remarkable contributions to their fields. We wanted to know what happens to a "genius" after the fellowship is over, so we spoke with Ramón Gutiérrez, a Preston and Sterling Morton Distinguished Service Professor in U.S. history at the University of Chicago, and one of the MacArthur fellows in 1983.
He told us about research in Chicano studies that fascinates him, what questions he asks in his own research, and what holes he sees in ethnic studies. During his time as a fellow, Gutiérrez wrote When Jesus Came the Corn Mothers Went Away, a monograph on marriage, sexuality and power in New Mexico.
Interview with Ramón Gutiérrez
How'd you react when you heard the news when you were a MacArthur fellow?
It was the second group of MacArthur fellows. I had read something about it, but I didn't know much about it. You know, when someone calls you up — I think the amount of money I had was something like $352,000 by 1982...
Related Articles
By Jessica Riskin, Los Ángeles Review of Books | 03.24.2026
This is the second part of the 14th installment in the Legacies of Eugenics series, which features essays by leading thinkers devoted to exploring the history of eugenics and the ways it shapes our present. You can read the...
By Jessica Riskin, Los Ángeles Review of Books | 03.23.2026
This is the first part of the 14th installment in the Legacies of Eugenics series, which features essays by leading thinkers devoted to exploring the history of eugenics and the ways it shapes our present. The series is organized by...
By Judd Boaz and Elise Kinsella, ABC News | 03.17.2026
By Carolyn Riley Chapman and Nirvan Bhatia, Hastings Bioethics Forum | 03.12.2026
Last year, researchers saved an infant named KJ from a life-threatening rare metabolic disorder using a customized gene editing therapy. This was the first time that an individualized gene therapy was used to treat a human patient, and it has...